Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo Controlled, First-in-Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Infusion of XTMAB-16 in Healthy Adult Participants
Conditions
Interventions
Placebo
XTMAB-16 2 mg/kg
+1 more
Locations
1
United States
MedStar Harbor Hospital
Baltimore, Maryland, United States
Start Date
June 25, 2021
Primary Completion Date
March 18, 2022
Completion Date
March 18, 2022
Last Updated
January 14, 2025
NCT07310901
NCT06342713
NCT07471204
NCT07401472
NCT07412353
NCT07231497
Lead Sponsor
Xentria, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions